跳至主要内容
临床试验/NCT06192238
NCT06192238尚未招募不适用

A National Multicenter Study of Adrenal Venous Sampling for the Subtype Diagnosis of Primary Aldosteronism in China

Chinese Academy of Medical Sciences, Fuwai Hospital48 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,500
试验地点
48
主要终点
The success rate of bilateral adrenal venous sampling

研究概览

简要总结

This multicenter study intends to combine retrospective analysis and prospective registry to evaluate the success rate and safety of adrenal venous sampling (AVS) via antecubital and femoral approach for patients with primary aldosteronism. The consistency of AVS with pathological results and clinical outcomes, the factors affecting the success of AVS, and the optimal population for AVS will be aslo analyzed in this study.

详细描述

Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, and its most common subtypes are aldosterone-producing adenoma and idiopathic hyperaldosteronism, which account for 95% to 98% of PA. Subtype diagnosis is crucial for the treatment of primary aldosteronism, which conducts the appropriate treatment strategy. Currently, adrenal venous sampling (AVS) serves as the gold standard for subtyping of PA. How to improve the success rate of AVS has been a hot topic in the field of primary aldosteronism. This multicenter registry study intends to combine retrospective analysis and prospective registry to evaluate the success rate and safety of AVS via antecubital and femoral approach for patients with primary aldosteronism. The consistency of AVS with pathological results and clinical outcomes, the factors affecting the success of AVS, and the optimal population for AVS will be also analyzed in this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged from 18 to 65 with no limits in sex;
  • Patients with confirmed primary aldosteronism;
  • Patients or their legal representatives sign written informed consent approved by the ethics committee;

排除标准

  • Severe comorbidity, including stroke, myocardial infarction, heart failure, severe valvular heart disease, liver cirrhosis, and metastatic tumor within the previous 3 months;
  • An estimated glomerular filtration rate <45 ml/min/1.73 m2, or serum creatinine >176 μmol/L;
  • Patients who refuse adrenalectomy;
  • Suspected of having an adrenocortical carcinoma;
  • Allergy to contrast agent;
  • Pregnant, nursing, or planning to become pregnant

结局指标

主要结局

The success rate of bilateral adrenal venous sampling

时间窗: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava \>2 without ACTH simulation)

次要结局

  • The success rate of left adrenal venous sampling(At AVS procedure)
  • The success rate of right adrenal venous sampling(At AVS procedure)
  • Time of the procedure(At AVS procedure)
  • The contrast agent dosage(At AVS procedure)
  • pathological results(If the patient underwent adrenalectomy)(1 week After AVS procedure)
  • the cost of the procedure(At AVS procedure)
  • Time of fluoroscopy(At AVS procedure)
  • the incidence of complications(1 week after AVS procedure)
  • Selection of intraoperative catheter(At AVS procedure)

研究者

发起方
Chinese Academy of Medical Sciences, Fuwai Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiongjing Jiang

professor

Chinese Academy of Medical Sciences, Fuwai Hospital

研究点 (48)

Loading locations...

相似试验